Provider [Proveedor] QP62-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2024 Leer más Fecha de entrada en vigencia del programa: 14 de agosto de 2024